Sponsor Pipeline

JCR Pharmaceuticals Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
2
Recruiting
3
Phase 3
Active Trials by Phase
Phase 3
2
Phase 2/3
1
Phase 2
1
Phase 1/2
3
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05594992 An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II… Mucopolysaccharidosis II Enrolling by Invitation
NCT04573023 A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT) Mucopolysaccharidosis II Active, Not Recruiting
Phase 2/3
NCT04348136 An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II Mucopolysaccharidosis II Active, Not Recruiting
Phase 2
NCT03708965 An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II Mucopolysaccharidosis II Active, Not Recruiting
Phase 1/2
NCT06488924 An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB Mucopolysaccharidosis III-B Recruiting
NCT06095388 Phase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIA Mucopolysaccharidosis III-A Active, Not Recruiting
NCT07640984 A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB) Mucopolysaccharidosis IIIB Not Yet Recruiting
Not specified
NCT07615400 A Long-Term Observational Study of Patients With Fucosidosis Fucosidosis Recruiting
Get alerts when JCR Pharmaceuticals Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free